Description
A prodrug of benazeprilat; inhibits enzymatic activity of partially purified ACE isolated from rabbit lung (IC50 = 2 nM); decreases the triglyceride and total cholesterol levels in normotensive rats (30 mg/kg); decreases aortic atherosclerosis in cholesterol-fed rabbits (3 mg/kg per day); reduces blood pressure in spontaneously hypertensive rats (0.1-10 mg/kg per day); decreases proteinuria in cats with chronic kidney disease (0.5-1 mg/kg per day)
Formal name: (3S)-3-[[1S-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride
Synonyms: CGS 14824A
Molecular weight: 461
CAS: 86541-74-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Angiotensin-converting Enzyme||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Kidney & Renal Disease|Chronic Kidney Disease||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism